Bruton's tyrosine kinase inhibitors: a promising emerging treatment option for multiple sclerosis.
Bruton's tyrosine kinase inhibitors: a promising emerging treatment option for multiple sclerosis.
Expert Opin Emerg Drugs. 2020 Sep 10;:
Authors: Carnero Contentti E, Correale J
PMID: 32910702 [PubMed - as supplied by publisher]
Source: Expert Opinion on Emerging Drugs - Category: Drugs & Pharmacology Tags: Expert Opin Emerg Drugs Source Type: research
More News: Drugs & Pharmacology | Multiple Sclerosis